Digital Transformation In Cell Therapy
Source: Cytiva
By Cytiva

To speed discovery and development and to create production process efficiencies, biopharmaceutical innovators are adopting machine learning, bioinformatics, and automation.
On a recent episode of The Business of Biotech, Dr. Mari Mitrani, co-founder and chief science officer of Organicell, and Dr. Michael Bellio, laboratory director, discussed how the clinical-stage regenerative medicine company has prioritized machine learning since its inception. Discover what they and other biopharmas are aiming to do with machine learning in the future.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Drug Discovery Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more